Log in to save to my catalogue

DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Auti...

DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Auti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1516771087

DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism

About this item

Full title

DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism

Publisher

United States: Public Library of Science

Journal title

PLoS genetics, 2014-03, Vol.10 (3), p.e1004241

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

One of the three most frequently documented copy number variations associated with autism spectrum disorder (ASD) is a 1q21.1 duplication that encompasses sequences encoding DUF1220 protein domains, the dosage of which we previously implicated in increased human brain size. Further, individuals with ASD frequently display accelerated brain growth a...

Alternative Titles

Full title

DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1516771087

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1516771087

Other Identifiers

ISSN

1553-7404,1553-7390

E-ISSN

1553-7404

DOI

10.1371/journal.pgen.1004241

How to access this item